Radiation Oncologist Expert Witness

Expert Witness No. 1316

Southern California

EMPLOYMENT

2005-Present
A Private Pharmaceutical Company, California
Chief Medical Officer
Vice President

2004-2005
Pfizer Inc., La Jolla, CA
Director, Oncology Clinical Development

1998-2004
University of California at San Diego School of Medicine
UCSD Cancer Center, San Diego, CA, Associate Professor

1994-1998
Massachusetts General Hospital / Harvard University School of Medicine, Boston, MA
Resident / Fellow Radiation Oncology
Board Certified 1998

1993-1994
University of Hawaii, Dept. of Medicine, Resident, PGY-1

FACULTY & STAFF POSITIONS / PRIVILEGES

1998-present
A University in California
Radiation Oncology
Cancer Center

Associate Professor / Voluntary from 2004-present

1998-2005
Veterans Administration Hospital
San Diego, California
Staff Physician WOC

1999-2004
Scripps Memorial Hospital
San Diego, California
Staff Physician WOC

POSTGRADUATE TRAINING

1994-1998
Massachusetts General Hospital / Harvard Medical School
Boston, Massachusetts
Dept. Radiation Oncology, Resident / Fellow

1993-1994
University of Hawaii, Honolulu, Hawaii
Dept. of Medicine, Intern (PGY-1)

EDUCATION

1988-1993
Stanford University Medical School
Palo Alto, California
M.D.

1984-1988
Johns Hopkins University
Baltimore, Maryland
B.A. Natural Sciences (Phi Beta Kappa)

PROFESSIONAL CERTIFICATION

MammoSite Certified, 2003
Intravascular Brachytherapy Certified, 2001
Gamma Knife Radiosurgery Certified, 2000
Medical Board of California- Medical License # Available upon request
American Board of Radiology (Radiation Oncology) - Board Certified, 1998
National Board of Medical Examiners - Diplomate, 1994
NCI Investigator # Available upon request

ORGANIZATIONS / MANAGEMENT

2005-2007
A Private Pharmaceutical Company
Chief Medical Officer and Vice President
Managed clinical development of oncology agents, including INDs and clinical trials
Established and managed clinical development department, including:
Hiring, managing and developing personnel, budgeting and process development
-Established development organizational structure
-Conducted partnering and public relations activities

2004-2005
Pfizer Inc., La Jolla, CA
Director Oncology
Developed and led clinical trials of oncology therapeutics
Establishing external and internal collaborations
(inc. clinical supportive studies, biomarkers, pharmacogenomics)
-Established and managed teams to set correlative preclinical study options to support clinical development strategies.
-Organized team to standardize clinical trial reporting methods between programs.

2003, NIH/NCI Study Section Grant Review Panel
2003, Imclone, Medical Advisory Board
2003, Medigene AG, Medical Advisory Board
2002, GlaxoSmithKline, Radiation Advisory Board
2001-2004, Children’s Oncology Group
2001, Schering Plough Clinical Investigators Group
1999-2004, UCSD Faculty Mentor Program
1999-2002, Radiation Therapy and Oncology Group (RTOG):
Principal Investigator for University of California at San Diego
1999-2004, Cancer and Leukemia Group B (CALGB)
2001-2004, University of California at San Diego School of Medicine Cancer Center:
Clinical Protocol Review Committee
1999-2004, University of California at San Diego School of Medicine Cancer Center:
Cancer Committee
1998-2004, University of California at San Diego School of Medicine Cancer Center:
Brain Tumor Unit, Asst. Director, Co-founder
-Developed clinical trials
-Developed marketing and clinical specialty programs
-Founded and managed drug discovery laboratory
1996-1998, Massachusetts General Hospital Executive Committee on Teaching and Education:
Graduate Medical Education Sub-Committee
1994-2007, American Society for Therapeutic Radiation Oncologists (ASTRO)
2001, 2002, 2003 Abstract Review and/or Session Moderator Annual Meeting
2004, 2005, 2006 Annual Meeting Educational Sessions Subcommittee
1991-1992, Pfizer Pharmaceuticals
-Designed re-organization of the Safety Assurance Div. for national safety data management in marketing clinical trials. 1991-1993, Stanford Medical Center Internal Review Board for Use of Human Subjects
1990, Stanford Health Policy Forum: Organizing Committee.
1989-1993, Arbor Free Clinic, Palo Alto CA: Co-founder and Steering Committee Member
1989-1991, Stanford University Medical School Admissions Panel

GRANTS

2003, RBF Foundation
2003, Univ. of California Academic Senate
2002, Children’s Oncology Group
2002, Wendy Will Case Cancer Foundation
2001, UC Cancer Research Coordinating Committee
2001, NIH P30 Molecular Imaging Center
2000, NIH P50 Molecular Imaging Center
1999, American Cancer Society

SOCIETY MEMBERSHIP

American Society for Therapeutic Radiation Oncologists (ASTRO)
2001, 2002, 2003 Abstract Review and/or Session Moderator Annual Meeting
2004, 2005, 2006, 2007 Annual Meeting Educational Sessions Subcommittee
American Society of Clinical Oncology (ASCO)
Children’s Oncology Group
American Association for the Advancement of Science
American Association for Cancer Research
American Medical Association
American College of Radiation Oncology

EDITORIAL REVIEWER

BioTechniques
Cancer Epidemiology, Biomarkers and Prevention
Cancer Gene Therapy
Current Cancer Drug Targets
CNS News
Gene Therapy
Genetic Vaccines and Therapy
Human Gene Therapy
Journal of Gene Medicine
Journal of Surgical Oncology
Microbes and Infection

LANGUAGES

Japanese
German

TEACHING RESPONSIBILITIES

Available upon request

COURSES TAUGHT

Medical Oncology Resident Lecture
Gene Therapy Program Seminar Lecture
Urology Grand Rounds
Head and Neck Surgery Resident Lecture
Neurosurgery Resident Journal Club Faculty Moderator
Medical Oncology Resident Lecture Roundtable
Medical Student Radiology Lecture
Neurosurgery Grand Rounds
Graduate Student Course Topics in Cancer Research (BIOM224) (Course Leader and Lecturer)
Biomedical and Clinical Research Center Seminar

TRAINING PROGRAMS

UCSD Faculty Mentor Program (12 students)

UCSD Medical School Senior Advisor (2 students)

UCSD Medical School Independent Study Project Advisor (3 students)

Presider for the UCSD Annual Undergraduate Research Conference (2000-2002)

BIBLIOGRAPHY

Available upon request

PUBLISHED ARTICLES

Available upon request

INVITED LECTURES

Available upon request

PATENTS

Available upon request

ABSTRACTS

Available upon request

REFERENCES

Available upon request

KEYWORDS

radiation oncology expert witness, angiogenesis expert witness, antisense technology expert witness, apoptosis expert witness, brain tumors expert witness, breast cancer expert witness, central nervous system expert witness, childhood brain tumors expert witness, clinical trial development expert witness, drug development expert witness, brachytherapy expert witness, seed implants expert witness, seeds expert witness, experimental therapeutics expert witness, gene therapy expert witness, giloma expert witness, integrins expert witness, leukemia expert witness, lymphoma expert witness, malignant giloma expert witness, pediatric cancer expert witness, pediatric oncology expert witness, radiation oncology expert witness, signal transduction expert witness, drug discovery expert witness, phage display expert witness, chemotherapy expert witness, radiation expert witness, clinical trials expert witness, targeting expert witness, HSV-1 expert witness, adenovirus expert witness, P450 expert witness, brain tumor expert witness, apoptosis expert witness, signal transduction expert witness, herpes expert witness, IL-4 expert witness, transferring expert witness, somatostatin expert witness

Or Contact Us @ 800-683-9847